Does PAZOPANIB Cause Hyperkeratosis? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Hyperkeratosis have been filed in association with PAZOPANIB (Pazopanib). This represents 0.1% of all adverse event reports for PAZOPANIB.
30
Reports of Hyperkeratosis with PAZOPANIB
0.1%
of all PAZOPANIB reports
8
Deaths
8
Hospitalizations
How Dangerous Is Hyperkeratosis From PAZOPANIB?
Of the 30 reports, 8 (26.7%) resulted in death, 8 (26.7%) required hospitalization, and 1 (3.3%) were considered life-threatening.
Is Hyperkeratosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAZOPANIB. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does PAZOPANIB Cause?
Death (3,767)
Diarrhoea (2,907)
Fatigue (1,883)
Nausea (1,879)
Malignant neoplasm progression (1,471)
Drug ineffective (1,135)
Decreased appetite (1,116)
Vomiting (1,072)
Hypertension (1,004)
Malaise (764)
What Other Drugs Cause Hyperkeratosis?
CABOZANTINIB S-MALATE (411)
ADALIMUMAB (332)
SUNITINIB MALATE (170)
ETANERCEPT (168)
SORAFENIB (150)
METHOTREXATE (149)
VEMURAFENIB (145)
REGORAFENIB (136)
RIPRETINIB (124)
RITUXIMAB (121)
Which PAZOPANIB Alternatives Have Lower Hyperkeratosis Risk?
PAZOPANIB vs PEANUT
PAZOPANIB vs PEG INTERFERON
PAZOPANIB vs PEG-INTERFERON ALFA 2A
PAZOPANIB vs PEGASPARGASE
PAZOPANIB vs PEGASYS